Literature DB >> 12766201

MG2 and lactoferrin form a heterotypic complex in salivary secretions.

R V Soares1, C C Siqueira, L S Bruno, F G Oppenheim, G D Offner, R F Troxler.   

Abstract

Protein-protein interactions are necessary for homeostasis to be maintained and for biological systems to be integrated. Heterotypic complexes occur in saliva, and a complex between MG2 and SIgA has been suggested to promote microbial clearance from the oral cavity. In this study, we used a peptide display library to investigate previously unrecognized heterotypic complexes involving MG2 and other proteins. The library was panned with MG2 12 times, and analyses of clones identified the sequence Ala-Leu-Leu-Cys-, which occurs in salivary lactoferrin. Blotting experiments confirmed that MG2 and lactoferrin form a heterotypic complex in vitro and in vivo. Periodate treatment of MG2 did not affect the interaction. A synthetic lactoferrin peptide containing the motif Ala-Leu-Leu-Cys-blocked the interaction between MG2 and lactoferrin, confirming the specificity of the interaction identified by panning. This complex may enhance the properties of these salivary components in the oral environment.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12766201     DOI: 10.1177/154405910308200613

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   6.116


  8 in total

1.  An unusual glycoform of human salivary mucin MG2.

Authors:  Rodrigo V Soares; Gwynneth D Offner; Marina A L Assis; Karine C Silva; Elton G Zenóbio
Journal:  Clin Oral Investig       Date:  2011-05-03       Impact factor: 3.573

2.  Streptococcus mutans surface alpha-enolase binds salivary mucin MG2 and human plasminogen.

Authors:  Jingping Ge; Diana M Catt; Richard L Gregory
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

3.  Human common salivary protein 1 (CSP-1) promotes binding of Streptococcus mutans to experimental salivary pellicle and glucans formed on hydroxyapatite surface.

Authors:  Kiran S Ambatipudi; Fred K Hagen; Claire M Delahunty; Xuemei Han; Rubina Shafi; Jennifer Hryhorenko; Stacy Gregoire; Robert E Marquis; James E Melvin; Hyun Koo; John R Yates
Journal:  J Proteome Res       Date:  2010-10-22       Impact factor: 4.466

4.  Multiple components contribute to ability of saliva to inhibit influenza viruses.

Authors:  M R White; E J Helmerhorst; A Ligtenberg; M Karpel; T Tecle; W L Siqueira; F G Oppenheim; K L Hartshorn
Journal:  Oral Microbiol Immunol       Date:  2009-02

Review 5.  Mucin-interacting proteins: from function to therapeutics.

Authors:  Shantibhusan Senapati; Srustidhar Das; Surinder K Batra
Journal:  Trends Biochem Sci       Date:  2009-11-11       Impact factor: 13.807

6.  Identification of salivary mucin MUC7 binding proteins from Streptococcus gordonii.

Authors:  Mehmet Kesimer; Nedret Kiliç; Ravi Mehrotra; David J Thornton; John K Sheehan
Journal:  BMC Microbiol       Date:  2009-08-11       Impact factor: 3.605

Review 7.  Exploring the role and diversity of mucins in health and disease with special insight into non-communicable diseases.

Authors:  Santosh Kumar Behera; Ardhendu Bhusan Praharaj; Budheswar Dehury; Sapna Negi
Journal:  Glycoconj J       Date:  2015-08-04       Impact factor: 3.009

8.  In Vitro Identification of Histatin 5 Salivary Complexes.

Authors:  Eduardo B Moffa; Maria A A M Machado; Maria C M Mussi; Yizhi Xiao; Saulo S Garrido; Eunice T Giampaolo; Walter L Siqueira
Journal:  PLoS One       Date:  2015-11-06       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.